» Articles » PMID: 36459733

Trends and Outcomes for Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in New South Wales from 2008 to 2019

Overview
Journal Am J Cardiol
Date 2022 Dec 2
PMID 36459733
Authors
Affiliations
Soon will be listed here.
Abstract

Risk profiles are changing for patients who undergo percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). In Australia, little is known of the nature of these changes in contemporary practice and of the impact on patient outcomes. We identified all CABG (n = 40,805) and PCI (n = 142,399) procedures in patients aged ≥18 years in New South Wales, Australia, during 2008 to 2019. Between 2008 and 2019, the age- and gender-standardized revascularization rate increased by 20% (from 267/100,000 to 320/100,000 population) for all revascularizations. The increase in revascularization was particularly driven by a 35% increase (from 194/100,000 to 261/100,000) in PCI, whereas the rate of CABG decreased by 20% (from 73/100,000 to 59/100,000). Mean age and the prevalence of co-morbidities (especially diabetes and atrial fibrillation) increased for patients with PCI in more recent years but remained consistently lower than for patients with CABG. CABGs performed in patients presenting with a non-ST-segment-elevation acute coronary syndrome halved from 34.3% to 18.7% during the study period, whereas PCIs in this group decreased from 36.5% to 29.6%. Risk-adjusted in-hospital mortality decreased by 7.5 deaths/1,000 procedures per month for CABG but remained unchanged for PCI. Risk-adjusted readmission rates were consistently higher for CABG than for PCI and did not change significantly over time. In conclusion, we observed a dramatic shift over time from CABG to PCI as the revascularization procedure of choice, with the patient base for PCI extending to older and sicker patients. There was a large decrease in mortality after CABG, whereas mortality after PCI remained unchanged.

Citing Articles

Application of Drug-Coated Balloons in Complex High Risk and Indicated Percutaneous Coronary Interventions.

Somsen Y, Rissanen T, Hoek R, Ris T, J Stuijfzand W, Nap A Catheter Cardiovasc Interv. 2024; 105(2):494-516.

PMID: 39660933 PMC: 11788978. DOI: 10.1002/ccd.31316.


Equity in Modifying Plaque of Women With Undertreated Calcified Coronary Artery Disease: Design and Rationale of EMPOWER CAD study.

McEntegart M, Gonzalo N, Fendelander L, West N, Lansky A J Soc Cardiovasc Angiogr Interv. 2024; 3(11):102289.

PMID: 39649816 PMC: 11624350. DOI: 10.1016/j.jscai.2024.102289.


Evolution of the Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Grafting (CABG) Indication and Mortality Rates in Spain from 2010 to 2019.

Gasulla O, Sarria-Santamera A, Mazaira-Font F, Garcia-Montero C, Fraile-Martinez O, Cantalapiedra D J Cardiovasc Dev Dis. 2024; 11(11).

PMID: 39590212 PMC: 11594947. DOI: 10.3390/jcdd11110369.


In-hospital outcomes by insurance type among patients undergoing percutaneous coronary interventions for acute myocardial infarction in New South Wales public hospitals.

Costa J, Pearson S, Brieger D, Lujic S, Shawon M, Jorm L Int J Equity Health. 2023; 22(1):226.

PMID: 37872627 PMC: 10594777. DOI: 10.1186/s12939-023-02030-1.